Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hennig

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmaceutical Research|October 10, 2020
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia TreatmentAhmed A H Abdellatif, Robert Hennig, Klaus Pollinger, et al.
Plos One|December 27, 2014
Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passageLeonie Herrnberger, Robert Hennig, Werner Kremer, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 14, 2012
Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticlesKlaus Pollinger, Robert Hennig, Miriam Breunig, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2015
Multivalent nanoparticles bind the retinal and choroidal vasculatureRobert Hennig, Andreas Ohlmann, Janina Staffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic applicationKlaus Pollinger, Robert Hennig, Andreas Ohlmann, et al.
ACS Nano|December 17, 2021
Magnetic Manipulation of Nanowires for Engineered Stretchable ElectronicsByron Llerena Zambrano, Csaba Forró, Erik Poloni, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmaceutical Research|October 10, 2020
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia TreatmentAhmed A H Abdellatif, Robert Hennig, Klaus Pollinger, et al.
Plos One|December 27, 2014
Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passageLeonie Herrnberger, Robert Hennig, Werner Kremer, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 14, 2012
Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticlesKlaus Pollinger, Robert Hennig, Miriam Breunig, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2015
Multivalent nanoparticles bind the retinal and choroidal vasculatureRobert Hennig, Andreas Ohlmann, Janina Staffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic applicationKlaus Pollinger, Robert Hennig, Andreas Ohlmann, et al.
ACS Nano|December 17, 2021
Magnetic Manipulation of Nanowires for Engineered Stretchable ElectronicsByron Llerena Zambrano, Csaba Forró, Erik Poloni, et al.
Pageof 2